Pubblicazioni

Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

2024 - BMC CANCER

Cirillo, Alessio; Marinelli, Daniele; Romeo, Umberto; Messineo, Daniela; De Felice, Francesca; De Vincentiis, Marco; Valentini, Valentino; Mezi, Silvia; Valentini, Filippo; Vivona, Luca; Chiavassa, Antonella; Cerbelli, Bruna; Santini, Daniele; Bossi, Paolo; Polimeni, Antonella; Marchetti, Paolo; Botticelli, Andrea

Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

2024 - BMC CANCER

Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells

2018 - BMC CANCER

Pelizzo, G.; Veschi, V.; Mantelli, M.; Croce, S.; Di Benedetto, V.; D'Angelo, P.; Maltese, A.; Catenacci, L.; Apuzzo, T.; Scavo, E.; Moretta, A.; Todaro, M.; Stassi, G.; Avanzini, M. A.; Calcaterra, V.